SHARE

Fior Markets launched a study titled “Global Leukapheresis Market by Type (Leukapheresis Devices, Leukapheresis Disposables), Application, End-Users, Region” and Global Forecast 2018-2025.

The global leukapheresis market is expected to reach USD 19.29 Million in 2017 to USD 41.07 Million by 2025 at a CAGR of 9.60% during the forecast period from 2018-2025. Increasing incidence and prevalence of leukemia,  demand for leukopaks for research applicationsare anticipated to drive the growth of the market.

GET FREE SAMPLE REPORT:https://www.fiormarkets.com/report-detail/375981/request-sample

The leukapheresis disposables segment accounted for the largest market share of around 58.17% in 2017

The type segment is classified into leukapheresis devices and leukapheresis disposables.The leukapheresis disposables segment accounted for the largest market share of around 58.17% in 2017. The increasing applications for the isolation of primary cells from blood for cell therapy research applications is estimated to drive the growth of the segment.

The research applications segment is dominating and was valued around USD 11.13 million in 2017

Applications segment is divided into research applications and therapeutic applications. The research applications segment is dominating and was valued around USD 11.13 million in 2017.Growing adoption in research activities for cancer, immunology, infectious diseases, drug discovery, regenerative medicine, and cell-based therapies are contributing to the growth of the segment.

The blood component providers & blood centers segment is expected to grow with the highest CAGR of 12.31% in the forecast period

End user segment is classified intoblood component providers and blood centers, academic and research institutes, pharmaceutical and biotechnology companies and hospitals and transfusion centers. The blood component providers & blood centers segment is expected to grow with the highest CAGR of 12.31% in the forecast period. Increasing number of blood donations and rising demand for leukopaks in clinical conditions like cancer are driving the growth.

BROWSE COMPLETE REPORT AND TABLE OF CONTENTS:https://www.fiormarkets.com/report/global-leukapheresis-market-by-type-leukapheresis-devices-leukapheresis-375981.html

Regional Segmentation Analysis:

The market is analysed on the basis of five regions namely North America, Europe, Asia Pacific, South America, and Middle East and Africa. Asia Pacificregion dominated the marketand was valued around USD 10.36 Million in 2017 followed by North America and Europe. Asia pacific is projected to be fastest growing region in the forecast period due to ongoing regenerative medicine research in the region, rise in the number of clinical trials and the presence of leading pharma and biotech companies in the region.

Competitive Analysis:

Major industry players in the market include Asahi Kasei Medical Co., Ltd, Macopharma SA, Fresenius Se & Co. KGaA, Bioivt, Haemonetics Corporation, PPA Research Group, Inc., Hemacare Corporation, Key Biologics, LLC, Terumo BCT, ALLCells, LLC, Stemexpress, LLC, Stemcell Technologies, Inc., CaltagMedsystems Limited, Zenbio, Inc, Precision for Medicine, Incand others.


Customization of the Report:This report can be customized to meet the client’s requirements. Please connect with our sales team(sales@fiormarkets.com),who will ensure that you get a report that suits your needs.